HortaPharm B.V. was a cannabis research business headquartered in the Netherlands.[1]
History
The business was founded by the late American, David Watson, in the early 1990s, with seeds he created for his company, Sacred Seeds in California. David W. Pate and Robert C. Clarke were employed by the company.[2] From September 1994 until September 1997 HortaPharm had a permit from the Dutch Ministry of Health for scientific research of cannabis. In 1998, HortaPharm B.V. began work with GW Pharmaceuticals to develop cannabis strains for the manufacture of pharmaceuticals.[3]
Research
HortaPharm B.V. has used selective breeding and production for research of cannabis strains, with a focus on the isolation of tetrahydrocannabinol or cannabidiol.[4]